Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Advanced Fibrosis in Type 2 Diabetes Mellitus Patients. Pjmcr 2026, 5 (1), 163-174. https://doi.org/10.5281/zenodo.18345788.